3 May 2013 --- DSM and Kemin have welcomed the results of the latest trial to indicate that the nutritional intake of lutein, zeaxanthin and omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs) may be beneficial for patients affected by age-related macular degeneration (AMD).
